Collection: EFA's

IHN’s Enhanced 𝝮3 is a patented monoglyceride omega-3 fatty acid researched and developed in Canada. The innovative MaxSimil delivery system was shown to have superior absorption than the next leading brands of ethyl ester (EE) or reconstituted triglyceride (rTG) fish oil.

Omega-3 fatty acid has a long standing use as a food based therapy with cellular antioxidant and anti-inflammatory properties ,  Clinicians' expertise, evidence and patients' value are three key factors guiding evidence based selection of omega 3 fatty acid.